arthritis due to psoriasis arthritis psoriatica
Conditions
Interventions
None listed
Sponsors
Erasmus MC, Universitair Medisch Centrum Rotterdam
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: Participant is 18 years or older Participant gives written consent for the prospective study Participant is willing and able to complete different questionnaires in Dutch language Participant agrees with blood testing for allergy (Total IgE, RAST inhalation allergy, serum cytokines and cytokine genes)
Exclusion criteria
Exclusion criteria: Participant is 17 years or younger Participant refuses blood testing for allergy Participant is pregnant or gives breastfeeding
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Prevalence of Th2-cell mediated disease as asthma, allergic rhinoconjunctivitis, atopic dermatitis and hand eczema in groups of patients with psoriatic arthritis, rheumatoid arthritis, cutaneous psoriasis, melanocytic naevi and phlebological problems. 4. Results of tests of total IgE, RAST inhalation allergies, Th1, Th2 and Th17 cytokines and genetic variation in genes coding for these cytokines in groups of patients with psoriatic arthritis, rheumatoid arthritis, cutaneous psoriasis, melanocytic naevi and phlebological problems. | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of life and (subjective) general health in groups of patients with psoriatic arthritis, rheumatoid arthritis, cutaneous psoriasism, melanocytic naevi and patients with a phlebological problem. | — |
Countries
Netherlands
Outcome results
None listed